Literature DB >> 19601575

Formation of a unique end-to-end stacked pair of G-quadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-quadruplex-interactive ligands.

SunMi L Palumbo1, Scot W Ebbinghaus, Laurence H Hurley.   

Abstract

The hTERT core promoter contains a G-rich region of 12 consecutive G-tracts, embracing 3 Sp1 binding sites, and has the potential to form multiple G-quadruplexes. From the 12 runs of guanines, 9 putative hTERT G-quadruplex-forming sequences were selected to assay for G-quadruplex formation and stability using circular dichroism and a Taq polymerase stop assay. Results from biophysical and chemical assays demonstrate an approximate inverse correlation between total loop size and structure stability. Investigation of the full-length hTERT G-rich sequence using a Taq polymerase stop assay and dimethyl sulfate footprinting revealed the formation of a unique end-to-end stacked G-quadruplex structure from this sequence. This structure consists of an all parallel G-quadruplex, formed by four consecutive G-tracts, linked to another, atypical G-quadruplex, formed by two pairs of consecutive G-tracts separated by a 26-base loop. This 26-base loop likely forms a stable hairpin structure, which would explain the unexpected stability of this G-quadruplex. Significantly, the formation of this tandem G-quadruplex structure in the full-length sequence masks all three Sp1 binding sites, which is predicted to produce significant inhibition of hTERT promoter activity. Furthermore, our study implies that inhibition of telomerase activity by some G-quadruplex ligands is not only produced by targeting telomeric G-quadruplexes but also by stabilization of the hTERT promoter G-quadruplexes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601575      PMCID: PMC2761083          DOI: 10.1021/ja902281d

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  62 in total

1.  Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing.

Authors:  Dennis Gomez; Thibault Lemarteleur; Laurent Lacroix; Patrick Mailliet; Jean-Louis Mergny; Jean-François Riou
Journal:  Nucleic Acids Res       Date:  2004-01-16       Impact factor: 16.971

2.  Mechanism of acridine-based telomerase inhibition and telomere shortening.

Authors:  Mekala Gunaratnam; Olga Greciano; Cristina Martins; Anthony P Reszka; Christoph M Schultes; Hamid Morjani; Jean-Francois Riou; Stephen Neidle
Journal:  Biochem Pharmacol       Date:  2007-06-16       Impact factor: 5.858

3.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

4.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy.

Authors:  Mitsuhiro Nakamura; Kenkichi Masutomi; Satoru Kyo; Manabu Hashimoto; Yoshiko Maida; Taro Kanaya; Masaaki Tanaka; William C Hahn; Masaki Inoue
Journal:  Hum Gene Ther       Date:  2005-07       Impact factor: 5.695

6.  Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.

Authors:  Xiao-Hua Fu; Jian-Song Zhang; Na Zhang; Yang-De Zhang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

7.  Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.

Authors:  D Xu; Q Wang; A Gruber; M Björkholm; Z Chen; A Zaid; G Selivanova; C Peterson; K G Wiman; P Pisa
Journal:  Oncogene       Date:  2000-10-26       Impact factor: 9.867

8.  The tail of the telomere.

Authors:  Luigi Petraccone; John O Trent; Jonathan B Chaires
Journal:  J Am Chem Soc       Date:  2008-12-10       Impact factor: 15.419

9.  Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.

Authors:  Kai Kraemer; Susanne Fuessel; Axel Meye
Journal:  Methods Mol Biol       Date:  2007

10.  Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene.

Authors:  Kexiao Guo; Vijay Gokhale; Laurence H Hurley; Daekyu Sun
Journal:  Nucleic Acids Res       Date:  2008-07-09       Impact factor: 16.971

View more
  89 in total

Review 1.  Targeting DNA G-quadruplex structures with peptide nucleic acids.

Authors:  Igor G Panyutin; Mykola I Onyshchenko; Ethan A Englund; Daniel H Appella; Ronald D Neumann
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression.

Authors:  Yong Qin; Jessica S Fortin; Denise Tye; Mary Gleason-Guzman; Tracy A Brooks; Laurence H Hurley
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

3.  Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity.

Authors:  Timo Quante; Benjamin Otto; Marie Brázdová; Iva Kejnovská; Wolfgang Deppert; Genrich V Tolstonog
Journal:  Cell Cycle       Date:  2012-08-21       Impact factor: 4.534

4.  Insights into the biomedical effects of carboxylated single-wall carbon nanotubes on telomerase and telomeres.

Authors:  Yong Chen; Konggang Qu; Chuanqi Zhao; Li Wu; Jinsong Ren; Jiasi Wang; Xiaogang Qu
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

5.  Expression of the human telomerase reverse transcriptase gene is modulated by quadruplex formation in its first exon due to DNA methylation.

Authors:  Pei-Tzu Li; Zi-Fu Wang; I-Te Chu; Yen-Min Kuan; Ming-Hao Li; Mu-Ching Huang; Pei-Chi Chiang; Ta-Chau Chang; Chin-Tin Chen
Journal:  J Biol Chem       Date:  2017-10-30       Impact factor: 5.157

6.  Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.

Authors:  Nanjie Deng; Lauren Wickstrom; Piotr Cieplak; Clement Lin; Danzhou Yang
Journal:  J Phys Chem B       Date:  2017-11-09       Impact factor: 2.991

Review 7.  DNA secondary structures: stability and function of G-quadruplex structures.

Authors:  Matthew L Bochman; Katrin Paeschke; Virginia A Zakian
Journal:  Nat Rev Genet       Date:  2012-10-03       Impact factor: 53.242

Review 8.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

9.  The i-motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern.

Authors:  Samantha Kendrick; Yoshitsugu Akiyama; Sidney M Hecht; Laurence H Hurley
Journal:  J Am Chem Soc       Date:  2009-12-09       Impact factor: 15.419

10.  Homologous PNA Hybridization to Noncanonical DNA G-Quadruplexes.

Authors:  Karen A Kormuth; John L Woolford; Bruce A Armitage
Journal:  Biochemistry       Date:  2016-03-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.